Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Targeted physical activity for frail pancreatic cancer patients on neoadjuvant chemotherapy

Official title: Pilot Study Evaluating the Impact of Targeted Physical Activity Among Frail Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Run by University of Illinois Chicago · NCT07647250 · Data updated 2026-11-12

This study tests a supervised, low‑intensity resistance exercise program to see if it helps frail or pre‑frail adults with pancreatic cancer who are receiving neoadjuvant chemotherapy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorUniversity of Illinois Chicago
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJune 22, 2026
Main results expectedApril 30, 2031
Study endsApril 30, 2032
Registry record updatedJune 24, 2026
Trial IDNCT07647250 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with potentially resectable pancreatic cancer who are frail or pre‑frail and planned for or currently receiving neoadjuvant chemotherapy.

Probably not a fit

Patients who do not experience functional improvements or who cannot safely participate in supervised exercise may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates a 36‑session, twice‑weekly targeted physical exercise program delivered to frail or pre‑frail adults with potentially resectable pancreatic cancer undergoing neoadjuvant chemotherapy. The goal is to determine feasibility and safety of the program and to generate preliminary estimates of changes in functional outcomes. The study uses a supervised, individualized approach to improve strength and functional performance through resistance-based activities, with assessments planned to inform the design of a larger future trial. Eligibility requires adults 18 and older with pancreatic cancer planning or receiving neoadjuvant chemotherapy who meet predefined frailty criteria, and the ability to consent and complete assessments in English or Spanish. The lead sponsor is the University of Illinois Chicago, conducted at the University of Illinois Clinical Cancer Center in Chicago, IL.

Why it matters

Potential benefit: If successful, participants could experience improved physical function and tolerance to chemotherapy, potentially supporting better treatment continuity and surgical readiness.

How similar studies have gone: Previous work in similar cancer populations suggests targeted exercise can be feasible and may improve function, but this specific frailty‑focused, neoadjuvant pancreatic cancer program is a novel evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years
2. Diagnosis of pancreatic cancer that is potentially resectable per the treating clinical team's assessment.
3. Planned to receive or actively receiving neoadjuvant chemotherapy prior to surgery.
4. Frail or pre-frail as defined by the protocol-specified frailty assessment tool (e.g., Fried Frailty Phenotype; pre-frail = 1-2 criteria; frail =\> 3 criteria).
5. Able to provide written informed consent.
6. Medically appropriate to participate in supervised, symptom-limited exercise as determined by study screening and, if indicated, the treating clinician's input.
7. Able to complete study assessments and questionnaires in English or Spanish (using IRB- approved instruments/materials).

Exclusion Criteria:

1. Adults unable to consent.
2. Medical condition that, in the judgment of the investigator and/or treating clinician, makes exercise unsafe (e.g., unstable angina, uncontrolled arrhythmia, decompensated heart failure, uncontrolled severe pulmonary disease).
3. Any absolute contraindication to exercise participation/testing per institutional standards.
4. Severe symptoms or functional impairment that prevents safe participation despite program modification.
5. Inability to comply with the intervention schedule and study procedures despite reasonable scheduling accommodations.

Where it's running

  • University of Illinois Clinical Cancer Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.